Skip to main content

New Products

  • Impax Labs to market generic or authorized generic version of OxyContin under deal with Purdue Pharma

    HAYWARD, Calif. — Impax Labs has settled a patent-infringement suit filed by Purdue Pharma concerning the opioid painkiller OxyContin, Impax said Tuesday.

  • Infirst Healthcare to promote pediatric cough-cold brand Dr. Cocoa in U.S. market

    LONDON — Infirst Healthcare earlier this month secured the rights to market Dr. Cocoa, an award-winning cocoa-flavored pediatric cough remedy.

    “Many cough treatments have deficiencies in their efficacy, safety and compliance profiles and Infirst Healthcare is committed to finding solutions that address these issues," Manfred Scheske, Infirst CEO said. "Introducing compliance optimized pediatric products that taste better to children is a step in this direction. We are excited about the start of our U.S. operations in the pediatric OTC market.

  • Roxane Labs' generic prostate drug gets tentative approval from FDA

    SILVER SPRING, Md. — The Food and Drug Administration has given tentative approval to a generic drug used to treat prostate disease, agency records showed.

    The FDA granted tentative approval to Roxane Labs' dutasteride capsules in the 0.5-mg strength. The drug is a generic version of GSK's Avodart, used to treat benign prostatic hyperplasia.

    Tentative approval means that a drug meets the agency's conditions for approval, but can't receive final approval until Avodart loses its patent protection, which will occur in 2015.

     

  • Sandoz to market authorized generic version of Adderall XR

    PHILADELPHIA — Sandoz will market an authorized generic version of an attention deficit hyperactivity disorder drug made by Shire under a contract between the two companies, Shire said Monday.

    Shire said Sandoz, the generics division of Swiss drug maker Novartis, would market an authorized generic version of Adderall XR (amphetamine; dextroamphetamine).

  • Rememband announces Kickstarter launch for new bracelet

    MINNEAPOLIS — Rememband announced on Monday the launch of the Rememband silicon bracelet on Kickstarter, a crowd-funding website.  

  • FDA approves Jubilant Life Sciences' quetiapine fumarate tablets

    NOIDA, India — The Food and Drug Administration has approved a generic version of a drug for schizophrenia and bipolar disorder made by Jubilant Life Sciences, the Indian drug maker said.

    Jubilant announced the approval of quetiapine fumarate tablets in the 25-mg strength. The drug is a generic version of AstraZeneca's Seroquel.

    Various versions of the drug have annual sales of about $59 million, according to IMS Health.

     

  • Karina Hair Accessories launches holiday collection

    NEW YORK — As the glamour and glitz of the winter season approaches, women are looking for hair accessories to complement their apparel. Enter Karina Hair Accessories.

  • Tidy Cats introduces new line of lighter litter

    ST. LOUIS — Cat litter brand Tidy Cats has introduced new LightWeight 24/7 Performance cat litter, which is 50% lighter in weight than traditional scooping cat litter.

    A recent survey of cat owners revealed that 61% of owners hate dealing with heavy cat litter; 35% agreed that one of the top challenges with heavy litters is the inability to carry other items at the same time when bringing it into their home.

X
This ad will auto-close in 10 seconds